iHuman Inc.
IHUnited States
7 filed reports · 214 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
7 reports · Mar 2025 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 6 operating metrics.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Interim · 6-KSEC EDGAR | 6 | 141 | Mar 2025 to Jun 2026 |
| Annual · 20-FSEC EDGAR | 1 | 829 | Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 6-K | Jun 30, 2026 | Sep 29, 2026 | 15 | Open |
| FY2026 Q1 | 6-K | Mar 31, 2026 | Jun 29, 2026 | 16 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Apr 24, 2026 | 829 | Open |
| FY2025 Q4 | 6-K | Dec 31, 2025 | Mar 31, 2026 | 32 | Open |
| FY2025 Q3 | 6-K | Sep 30, 2025 | Dec 29, 2025 | 36 | Open |
| FY2025 Q2 | 6-K | Jun 30, 2025 | Sep 18, 2025 | 31 | Open |
| FY2025 Q1 | 6-K | Mar 31, 2025 | Jun 26, 2025 | 11 | Open |
Financial data
214 concepts · 970 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial213 concepts · 964 facts · Dec 2023 to Jun 2026
- Revenue18 · Dec 2023 to Jun 2026
- Gross Profit14 · Mar 2024 to Jun 2026
- Net Income14 · Mar 2024 to Jun 2026
- Operating Income14 · Mar 2024 to Jun 2026
- Pretax Income14 · Mar 2024 to Jun 2026
- Cost of Revenue13 · Mar 2024 to Mar 2026
- General and Administrative Expense13 · Mar 2024 to Mar 2026
- Income Tax Expense (Benefit)13 · Mar 2024 to Mar 2026
- R&D Expense13 · Mar 2024 to Mar 2026
- Selling and Marketing Expense13 · Mar 2024 to Mar 2026
- Allowance for doubtful accounts receivable current10 · Dec 2023 to Dec 2025
- Cash cash equivalents restricted cash and restricted cash equivalents10 · Dec 2023 to Dec 2025
- Stockholders equity (US GAAP)8 · Dec 2023 to Dec 2025
- Accounts payable current6 · Dec 2024 to Dec 2025
- Accounts receivable gross current6 · Dec 2024 to Dec 2025
- Accounts receivable net current6 · Dec 2024 to Dec 2025
- Accrued expenses and other current liabilities (including amounts of the consolidated VIE and VIE's subsidiaries without recourse to the primary beneficiary of RMB 100,213 and RMB 91,935 (US$ 13,147) as of December 31, 2024 and 2025, respectively)6 · Dec 2024 to Dec 2025
- Accrued liabilities current6 · Dec 2024 to Dec 2025
- Accrued salaries current6 · Dec 2024 to Dec 2025
- Accumulated depreciation depletion and amortization property plant and equipment6 · Dec 2024 to Dec 2025
- Accumulated other comprehensive income loss net of tax6 · Dec 2024 to Dec 2025
- Additional paid in capital6 · Dec 2024 to Dec 2025
- Amount transferred to PRC statutory reserve funds6 · Dec 2024 to Dec 2025
- Assets6 · Dec 2024 to Dec 2025
KPI1 concepts · 6 facts · Mar 2025 to Mar 2026
- Monthly Active Users6 · Mar 2025 to Mar 2026
Segments
Figures broken down by business line, region, product or another axis the company reports on.
No segment breakdowns.
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.